Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics (NQ: CORT )

20.78 USD +0.49 (+2.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Corcept Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Corcept Therapeutics Incorporated (CORT) Q2 2021 Earnings Call Transcript
CORT earnings call for the period ending June 30, 2021. 
Tags CORT Market News
From Motley Fool
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BNTX Biotech AZN
From Benzinga
Corcept Therapeutics To Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
From GlobeNewswire News Releases
Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer
From GlobeNewswire News Releases
Corcept Therapeutics Stock Drops After Disappointing Interim Data From Relacorilant Plus Nab-Paclitaxel Trial In Pancreatic Cancer
Corcept Therapeutics Incorporated(NASDAQ: CORT) hasannounced preliminary resultsfrom its Phase 3 RELIANT trial of ... 
Tags General Benzinga Health Care
From Benzinga
Preliminary Results From RELIANT Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
From GlobeNewswire News Releases
CORT Makes Bullish Cross Above Critical Moving Average
In trading on Wednesday, shares of Corcept Therapeutics Inc (CORT) crossed above their 200 day moving average of $22.65, changing hands as high as $23.49 per share. Corcept Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
Wednesday 6/16 Insider Buying Report: CORT, ATRA
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
SHAREHOLDER ALERT: Barr Law Group Investigating CORT, SEMMX, MSEIX, and MIMFX; Shareholders are Encouraged to Contact the Firm
From GlobeNewswire News Releases
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
From GlobeNewswire News Releases
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
From GlobeNewswire News Releases
Corcept Stops Phase 2 NASH Study With Miricorilant Due To Elevated Liver Enzymes In Patients
Corcept Therapeutics Incorporated(NASDAQ:CORT) hasannounced interim datafrom the Phase 2 trial evaluating its ... 
Tags Market News Briefs Non Alcoholic steatohepatitis
From Benzinga
Corcept Therapeutics Incorporated (CORT) Q1 2021 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2021. 
Tags Market News CORT
From Motley Fool
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
From GlobeNewswire News Releases
Corcept Therapeutics Observes Large Reductions of Liver Fat and Transient Liver Enzyme Elevations in Phase 2 Trial of Miricorilant as a Potential Treatment for Patients with Nonalcoholic Steatohepatit
From GlobeNewswire News Releases
Addition of Relacorilant to Nab-Paclitaxel Improves Progression Free Survival (PFS) in Controlled, Phase 2 trial of 178 Patients with Platinum Resistant Ovarian Cancer
From GlobeNewswire News Releases
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AKUS EBS AXLA
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
Tags AQST PBYI GH
From Benzinga
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
From GlobeNewswire News Releases
How The Pieces Add Up: PJP Headed For $90
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
3 Healthcare Stocks That Could Be Millionaire-Makers
With solid revenue growth, these stocks have the potential to more than triple over the next few years. 
Tags CORT KMPH Market News
From Motley Fool
Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab (Keytruda®) in Patients with Adrenal Cancer with Cortisol Excess
From GlobeNewswire News Releases
Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer
From GlobeNewswire News Releases
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results
From GlobeNewswire News Releases
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IPOs PRTA APVO
From Benzinga
Why Corcept Therapeutics, Acasti Pharma And More Are Moving Today
Corcept Therapeutics (NASDAQ: CORT) shares were trading lower Tuesday after the company reported preliminary fourth-quarter sales ... 
Tags Small Cap Movers TMDX
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TRIB TERN ANIX
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers KalVista Pharmaceuticals (NASDAQ:KALV) stock rose 212.29% to $48.75 during Tuesday's pre-market session. The ... 
Tags TMDX Movers EKSO
From Benzinga
50 Stocks Moving in Tuesday's Pre-Market Session
Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares rose 91.4% to $8.08 in pre-market trading after climbing over 18% ... 
Tags GOVX Pre/Market Movers CVLB
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback